BioNTech SEBNTXNASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank93
3Y CAGR+283.9%
5Y CAGR+56.7%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+283.9%/yr
Quarterly compound
5Y CAGR
+56.7%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
9.4x
Strong expansion
Streak
2 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q3 2025 | 643.28% |
| Q2 2025 | 86.26% |
| Q1 2025 | -89.54% |
| Q4 2024 | -11.20% |
| Q3 2024 | 1447.02% |
| Q2 2024 | -46.38% |
| Q1 2024 | -90.11% |
| Q4 2023 | 77.22% |
| Q3 2023 | 15181.25% |
| Q2 2023 | -99.59% |
| Q1 2023 | -71.16% |
| Q4 2022 | 51.19% |
| Q3 2022 | 11.37% |
| Q2 2022 | -52.13% |
| Q1 2022 | 2.65% |
| Q4 2021 | 1.51% |
| Q3 2021 | 10.20% |
| Q2 2021 | 143.74% |
| Q1 2021 | 496.25% |
| Q4 2020 | 401.57% |
| Q3 2020 | 68.14% |
| Q2 2020 | 65.60% |
| Q1 2020 | -7.44% |
| Q4 2019 | -3.60% |
| Q3 2019 | 20.38% |
| Q2 2019 | -11.56% |
| Q1 2019 | -61.30% |
| Q4 2018 | 236.59% |
| Q3 2018 | -4.66% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |